Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection

Award Number: R21AI115291
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2015
PERIOD OF PERFORMANCE END DATE: 04/30/2018

Group Awards By:

View Award Description

Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection - ¿ DESCRIPTION (provided by applicant): Influenza (flu) is a highly contagious respiratory disease that affects millions of people each year with significant cost to the economy. Currently, influenza A virus (IAV) of the subtype H1N1 is responsible for seasonal epidemics that may result in severe respiratory illness and deaths worldwide. The annual Influenza virus epidemics are estimated to cost the U.S. 10.4 billion in direct medical expenses and 16.4 billion in lost potential earnings. The frequent appearances of new strains of flu made the generation of effective vaccines difficult. Therefore, the detailed molecular mechanisms how IAV replicates and propagates need to be investigated to design effective antiviral drugs and vaccines. Influenza induces cell death in infected cells to facilitate virus replication. Our preliminary studies identified the Bcl-2 interacting killer (Bik) as a crucial cellular protein promoting IAV infection in human airway epithelial cells (AECs) and in mice. We found that IAV replication was attenuated in bik-/- compared to bik+/+ cells, as indicated by reduced viral titers. Following infection, bik-deficient mouse airway epithelial cells (MAECs) showed more stable trans-epithelial resistance following infection, were less sensitive to infection-induced cell death, and had reduced levels of viral RNA compared to bik-sufficient MAECs. Knockdown of Bik reduced viral protein expression levels and the sensitivity of human airway epithelial cells (HAECs) to IAV-induced cell death. Survival analysis of mice infected with IAV showed that bik-/- mice survived for significantly longer days after infection and were 10-fold less likely to die from infection compared to bik+/+ mice. Additionally, the bik+/+ mice lost significantly more weight compared to the bik-/- mice. IAV activated caspase 3 in a Bik-dependent manner and cleavage of viral NP and M2 proteins were inhibited when Bik was knocked down, implying that Bik-mediated caspase cleavage of viral proteins is linked to virus replication. Thus, we hypothesize that Bik is crucial for intracellular cleavage of components of viral protein(s) to promote virus replication. Although cleavage of viral proteins has been shown to promote virus infectivity, littl is known about relevant host cell proteases. This study will investigate the role of caspases in enhancing virus infectivity and tests whether targeted inhibition of caspases mitigate IAV infectivity. This hypothesis will be tested in Specific Aims 1 and 2. Aim 1 will investigate whethe Bik mediates caspase-dependent cleavage of viral proteins in IAV infected cells. Aim 2 will determine whether modulating the expression of Bik or inhibition of caspase activations mitigate viral replication and susceptibility to IAV- induced mortality in vivo. A better understanding of te molecular mechanisms how IAV manipulates host cellular proteins to facilitate virus replication will provide insight into new therapeutic approaches that target cellular and/or viral proteins to reduce infection and disease progression in humans.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2016	LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC.	2425 RIDGECREST DR SE	ALBUQUERQUE	NM	87108	BERNALILLO	USA	Allergy and Infectious Diseases Research	000	2	10/1/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2018 ( Subtotal = $0 )
2018	2016	LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC	2425 RIDGECREST DR SE	ALBUQUERQUE	NM	87108	BERNALILLO	USA	Allergy and Infectious Diseases Research	000	2	9/6/2018	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2016 ( Subtotal = $327,000 )
2016	2016	LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE	POST OFFICE BOX 5890	ALBUQUERQUE	NM	87185	BERNALILLO	USA	Allergy and Infectious Diseases Research	000	2	4/18/2016	NON-COMPETING CONTINUATION	$327,000
														Subtotal = $327,000

Issue Date FY: 2015 ( Subtotal = $272,500 )
2015	2015	LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE	POST OFFICE BOX 5890	ALBUQUERQUE	NM	87185	BERNALILLO	USA	Allergy and Infectious Diseases Research	000	1	4/22/2015	NEW	$272,500
														Subtotal = $272,500

Grand Total All Awards = $599,500

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection

Award Number: R21AI115291

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2015

PERIOD OF PERFORMANCE END DATE: 04/30/2018

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer